Valued at $35.3 billion by market cap, San Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and cloud-based software applications for ...

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea ...

Dealership warranties usually offer expansive coverage and high-quality services. You’ll often be charged more for a dealership warranty due to additional interest. It’s best to examine ...

2030 ambition to help more than 500 million people worldwide achieve their full health potential Showcases integration of intelligent products and solutions within the ResMed ecosystem ...

NEW YORK — The morning after presenting an upbeat outlook to analysts in a gilded hall in the New York Stock Exchange building, Mick Farrell, the CEO of ResMed, looked refreshed, despite a post ...

Learn More ResMed (ASX: RMD) shares are outperforming the market on Tuesday. In afternoon trade, the sleep disorder treatment company's shares are up 2% to $35.73. This compares favourably to a 0. ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Sleep apnoea devices giant ResMed wants to hit high single-digit revenue growth over the next five years broadening its product range for insomnia and COPD sufferers. The US headquartered company ...

On Thursday, JPMorgan reaffirmed its confidence in ResMed (NYSE:RMD), maintaining an Overweight rating with a steady price target of $240.00. The firm's outlook suggests that while sales growth ...

Peter C. Farrell, Chairman Emeritus of ResMed Inc (NYSE:RMD), has sold 2,000 shares of the company's common stock, according to a recent SEC filing. The transaction, which took place on October 2, ...